Amgen announces positive phase-II data for investigational Olpasiran in adults with elevated lipoprotein(a) Read more
Amgen announces positive top-line results from Otezla phase-III Discreet study in moderate-to-severe genital psoriasis Read more
AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment Read more
US DOJ permits six drug makers to share info about COVID-19 MAb treatments to expedite production Read more